WCI

Login Sign Up Sitemap
Home > RI Related News > RI Related News

RI Related News

게시글 목록
No TItle Name Date Hit
785 U.S. Department of Energy Office of Science Awards $115M for High Rigidity Spectrometer Project at FRIB WCI Secretariat 2023/11/09 891
784 NorthStar to Suspend Production of Mo-99 Radioisotopes WCI Secretariat 2023/11/09 881
783 Lilly to Acquire POINT Biopharma to Expand Oncology Capabilitiesinto Next-Generation Radioligand Therapies WCI Secretariat 2023/10/06 898
782 Plus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a Trial for Leptomeningeal Metastase WCI Secretariat 2023/10/06 889
781 First Participant Treated Using NORTHSTAR MEDICAL RADIOISOTOPES’ Electron Accelerator-Produced Copper-67 (CU-67) in CLARITY PHARMACEUTICALS’ Phase I/IIA THERANOSTIC CLINICAL Trial Investigating CU-67 Sartate for Treatment of Neuroblastoma WCI Secretariat 2023/10/06 881
780 POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands WCI Secretariat 2023/10/06 868
779 Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients WCI Secretariat 2023/10/06 874
778 Orano Med and Orbit Discovery enter Collaboration to discover novel targeted radioligand therapies for cancer WCI Secretariat 2023/10/06 866
777 NORTHSTAR Medical Radioisotopes and Curadh MTR Announced A strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (AC-225) WCI Secretariat 2023/10/06 871
776 Leningrad Nuclear Plant Gets Approval to Make a New Isotope WCI Secretariat 2023/10/06 879
775 Isotopia Molecular Imaging to Set up Shop in Westfield WCI Secretariat 2023/10/06 899
774 Monrol Announced Investment to Increase Production Capacity for Lu-177 n.c.a. WCI Secretariat 2023/10/06 888
773 ITM, Helmholtz Munich and University Hospital Münster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma WCI Secretariat 2023/04/04 1053
772 ASP Isotopes Set for Commercial Launch with Completion of first Isotopes Enrichment Facility WCI Secretariat 2023/04/04 1094
771 Novartis completes FDA filing for approval of Millburn facility to support Pluvicto® launch WCI Secretariat 2023/04/04 1128
First Prev 1 2 3 4 5 6 7 8 9 10 End (55 Page)

비밀글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.